Amedisys, Inc. Amedisys, Inc.

Amedisys, Inc.

AMED

Helyezés a részvények között #4618
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Részvényárfolyam
$100.99
Utolsó szinkronizálás: 2025-08-15
Piaci kapitalizáció
$3.31B
Változás (1 nap)
0.00%
Változás (1 év)
0.00%
Ország
US
Kereskedés Amedisys, Inc. (AMED)

Kategória

Healthcare
Bevétel a(z) Amedisys, Inc. (AMED) részvényhez
Bevétel ekkor: Jun 2025 TTM: $2.40B
Amedisys, Inc. legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $2.40B. 2023 évben a vállalat $2.24B árbevételt ért el, amely növekedés a 2022 évben elért $2.22B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Amedisys, Inc. bevételtörténete 2000 és 2026 között
Bevétel az év végén
Év Bevétel Változtassa meg
2026 (TTM) $2.40B 2.30%
2024 $2.35B 5.01%
2023 $2.24B 0.59%
2022 $2.22B 0.41%
2021 $2.21B 6.88%
2020 $2.07B 5.93%
2019 $1.96B 17.63%
2018 $1.66B 8.40%
2017 $1.53B 6.69%
2016 $1.44B 12.25%
2015 $1.28B 6.31%
2014 $1.20B -3.59%
2013 $1.25B -16.03%
2012 $1.49B 1.19%
2011 $1.47B -10.03%
2010 $1.63B 7.99%
2009 $1.51B 27.46%
2008 $1.19B 70.13%
2007 $697.93M 28.97%
2006 $541.15M 41.83%
2005 $381.56M 68.02%
2004 $227.09M 59.39%
2003 $142.47M 10.08%
2002 $129.42M 17.47%
2001 $110.17M 21.40%
2000 $90.76M 0.00%
Hasonló cégek vagy versenytársak bevétele
Vállalat Bevétel Bevételkülönbség Ország
$78.01B 3,147.34%
US
- -
DE
$21.81B 807.94%
US
$3.89B 62.13%
SA
$11.08B 361.42%
BR